Transitional changes in the incidence of hip osteonecrosis among renal transplant recipients()

BACKGROUND: Immunosuppressive therapy for renal allograft recipients has changed substantially since the introduction of the anti-CD25 monoclonal antibody, basiliximab. We hypothesized that recent improvements in immunosuppressive treatment may reduce the incidence of osteonecrosis of the femoral he...

Descripción completa

Detalles Bibliográficos
Autores principales: Takao, Masaki, Abe, Hirohito, Sakai, Takashi, Hamada, Hidetoshi, Takahara, Shiro, Sugano, Nobuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Orthopaedic Association. Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135379/
https://www.ncbi.nlm.nih.gov/pubmed/31280930
http://dx.doi.org/10.1016/j.jos.2019.06.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135379/
https://www.ncbi.nlm.nih.gov/pubmed/31280930
http://dx.doi.org/10.1016/j.jos.2019.06.009

Ejemplares similares